Fiduciary Group’s Gilead Sciences GILD Stock Holding History

Fiduciary Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,709	Closed	-$200K	–	189
2015 Q2	$200K	Buy	+1,709	New	+$187K	0.06%	187

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fiduciary Group's GILD Position: Q3 2015 in Review

Fiduciary Group sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 1,709 shares — an estimated $200K sold.

Fiduciary Group first reported a position in GILD in Q2 2015 and held it in 1 quarter. The position peaked at $200K in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

Fiduciary Group reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
Fiduciary Group sold 1,709 Gilead Sciences shares in Q3 2015, an estimated $200K.
Fiduciary Group first reported a position in Gilead Sciences in Q2 2015 and held it in 1 quarter.
Fiduciary Group's Gilead Sciences position peaked at $200K in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Fiduciary Group's 13F filing for Q3 2015, filed 12 Nov 2015.